Jupiter Life Line Hospitals Ltd
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
- Market Cap ₹ 9,472 Cr.
- Current Price ₹ 1,445
- High / Low ₹ 1,770 / 1,250
- Stock P/E 50.6
- Book Value ₹ 217
- Dividend Yield 0.07 %
- ROCE 17.7 %
- ROE 13.5 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 43.4% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|
320 | 398 | 463 | 461 | 657 | 787 | 915 | 1,060 | 1,095 | |
266 | 333 | 380 | 392 | 498 | 583 | 687 | 791 | 817 | |
Operating Profit | 54 | 65 | 83 | 69 | 159 | 204 | 227 | 269 | 278 |
OPM % | 17% | 16% | 18% | 15% | 24% | 26% | 25% | 25% | 25% |
5 | 2 | 2 | 4 | 4 | 11 | 26 | 28 | 36 | |
Interest | 16 | 24 | 26 | 28 | 29 | 28 | 19 | 9 | 11 |
Depreciation | 20 | 24 | 26 | 27 | 28 | 29 | 31 | 42 | 51 |
Profit before tax | 24 | 20 | 33 | 18 | 106 | 159 | 204 | 246 | 252 |
Tax % | -25% | 8% | 10% | 5% | 20% | 33% | 25% | 25% | |
30 | 18 | 30 | 17 | 85 | 107 | 152 | 185 | 187 | |
EPS in Rs | 5.88 | 3.57 | 5.83 | 3.26 | 16.65 | 18.97 | 23.18 | 28.17 | 28.57 |
Dividend Payout % | 8% | 0% | 0% | 0% | 0% | 0% | 4% | 4% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 17% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 43% |
3 Years: | 29% |
TTM: | 16% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 11% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 17% |
Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 51 | 51 | 51 | 51 | 51 | 57 | 66 | 66 |
Reserves | 147 | 162 | 186 | 202 | 278 | 409 | 1,180 | 1,357 |
210 | 252 | 263 | 262 | 322 | 298 | 0 | 142 | |
63 | 71 | 94 | 100 | 104 | 123 | 115 | 145 | |
Total Liabilities | 470 | 537 | 594 | 615 | 755 | 885 | 1,361 | 1,710 |
379 | 431 | 435 | 426 | 465 | 476 | 477 | 713 | |
CWIP | 28 | 12 | 10 | 13 | 14 | 16 | 61 | 163 |
Investments | 1 | 2 | 2 | 65 | 71 | 95 | 111 | 208 |
63 | 92 | 146 | 109 | 205 | 297 | 711 | 626 | |
Total Assets | 470 | 537 | 594 | 615 | 755 | 885 | 1,361 | 1,710 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
43 | 46 | 75 | 113 | 142 | 184 | 110 | 220 | |
-43 | -58 | -43 | -78 | -68 | -130 | -238 | -173 | |
1 | 16 | -32 | -23 | 10 | -23 | 122 | 302 | |
Net Cash Flow | 1 | 3 | -1 | 12 | 84 | 31 | -6 | 348 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 20 | 24 | 35 | 16 | 15 | 19 | 18 | 13 |
Inventory Days | 60 | 46 | 64 | 45 | 38 | 42 | 39 | 35 |
Days Payable | 224 | 168 | 268 | 192 | 155 | 169 | 116 | 157 |
Cash Conversion Cycle | -144 | -98 | -169 | -132 | -101 | -108 | -59 | -110 |
Working Capital Days | 11 | 11 | 36 | 1 | -18 | -18 | -7 | -20 |
ROCE % | 10% | 12% | 9% | 23% | 27% | 22% | 18% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
9 Aug - Scheduled investor meetings on August 18, 2025, at JM Financial Conference, Mumbai, in-person.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
6 Aug - Q1 FY26: 20.5% revenue growth, new solar plant, ongoing hospital expansions, higher depreciation and finance costs.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
4 Aug - Audio link of Q1 FY26 earnings call available on company website.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
3 Aug - Of Newspaper Publication for Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2025.
-
Intimation Under Regulation 30(5) Of The Listing Regulation
1 Aug - Authorization of CFO and CEO for materiality determination and disclosures under SEBI Listing Regulations.
Concalls
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Oct 2023TranscriptNotesPPT
Hospital Portfolio[1][2]
The company operates 3 hospitals with 1,275 Doctors across:
a) Thane - 377 Operating Beds and 72.1% Average Occupancy
b) Pune - 309 Operating Beds and 54.9% Average Occupancy
c) Indore - 375 Operating Beds and 65.5% Average Occupancy